Our featured companies! Top picks


IM Cannabis Corp.

CNSX: IMCC


Canadian symbol: IMCC.CN
US symbol: IMCC

Currency in CAD

Valuation Measures

Market Cap (intraday) 5401.39M
Enterprise Value 3394.8M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)29.80
Price/Book (mrq)14.29
Enterprise Value/Revenue 329.31
Enterprise Value/EBITDA 6-103.98

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3557.14%
S&P500 52-Week Change 313.47%
52 Week High 33.5000
52 Week Low 30.1750
50-Day Moving Average 32.4088
200-Day Moving Average 31.7415

Share Statistics

Avg Vol (3 month) 3109.49k
Avg Vol (10 day) 342.92k
Shares Outstanding 5158.65M
Float 85.65M
% Held by Insiders 146.05%
% Held by Institutions 17.32%
Shares Short (Dec. 14, 2020) 45.45k
Short Ratio (Dec. 14, 2020) 40.05
Short % of Float (Dec. 14, 2020) 4N/A
Short % of Shares Outstanding (Dec. 14, 2020) 40.00%
Shares Short (prior month Nov. 12, 2020) 4135.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin -53.95%
Operating Margin (ttm)-33.06%

Management Effectiveness

Return on Assets (ttm)-10.14%
Return on Equity (ttm)-40.26%

Income Statement

Revenue (ttm)13.47M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)153.40%
Gross Profit (ttm)3.93M
EBITDA -3.8M
Net Income Avi to Common (ttm)-7.27M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.74M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)1.02M
Total Debt/Equity (mrq)3.36
Current Ratio (mrq)7.51
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-10.5M
Levered Free Cash Flow (ttm)-12.63M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
IMCC.CN
IM Cannabis
2 weeks ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
46.05%% of Shares Held by All Insider
7.32%% of Shares Held by Institutions
13.57%% of Float Held by Institutions
3Number of Institutions Holding Shares

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
Wasatch Microcap Fund11,325,643Sep. 29, 20207.13%13,590,771
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by IM Cannabis Corp.


IM Cannabis to Acquire Trichome in Landmark Transaction - Establishes Global Growth Platform and Leading Multi-Country Operator

IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator

Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating directly in Israel, the EU, and Canada, with forecast adjusted EBITDA profitability in 2021 IMC will leverage Trichome's premium indoor cultivation to meet growing demand for premium cannabis from ... Read More...
IM Cannabis Reports 57% Sequential Increase in Consolidated Revenues, Reaches Positive Adjusted EBITDA for Q3 2020

IM Cannabis Reports 57% Sequential Increase in Consolidated Revenues, Reaches Positive Adjusted EBITDA for Q3 2020

Consolidated revenues increased to $5.9 million in Q3 2020, a 57% sequential increase, while realizing gross margin before fair value impacts of 57%The Company reached positive adjusted EBITDA of $0.3 millionNASDAQ listing process progressing with expected listing early 2021* Currency is in CAD$ unless specified otherwiseTORONTO, ON and G... Read More...
IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

Shipments made to seven distribution partners in GermanyGerman operations and growing sales by Focus Medical create inflection point to positive adjusted EBITDA profitability beginning in September 2020IMC Netherlands has submitted its application to the Dutch government's controlled cannabis supply chain experiment* Currency is in CAD$ u... Read More...
IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

IMC has now completed shipments of its branded flower products to four of the Company's ten distribution partners, marking IMC's official brand launch in GermanyThree additional purchase commitments executed with German distributorsIMC now has binding purchase commitments for 1,615kg of medical cannabis* Currency is in CAD$ unless specifi... Read More...
IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling purchase commitments for IMC-branded productsAdjupharm adds Cansativa, Ilios and Farmako to its distribution network, platform now includes ten distributors* Currency is in CAD$ unless specified otherwiseTORONTO, GLIL YAM, Israel and ... Read More...
IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior year, a 62% increase, and a 180% increase over Q1 2020Gross margin before fair value impacts was 54% in Q2 2020Q2 2020 milestones include:* Currency is in CAD$ unless specified otherwiseTORONTO and GLIL YAM, Israel, Aug. 26, 2020 - IM Cannabis Corp. ... Read More...
Boost by Kaplan Teams Up with Find Your Grind to Inspire and Help Pre-College Students Chart their Education and Career Paths

Boost by Kaplan Teams Up with Find Your Grind to Inspire and Help Pre-College Students Chart their Education and Career Paths

Boost by Kaplan, an innovative online program designed to help pre-college students learn what careers look like and the skills needed to succeed in them, is working with Find Your Grind to deliver a highly engaging approach to learning and navigating the path to self-discovery and success. Find Your Grind offers an extensive library of m... Read More...
Boost by Kaplan Partners with The Myers–Briggs Company to Help Students Assess How Their Interests Can Translate to Increased College Readiness and Career Success

Boost by Kaplan Partners with The Myers–Briggs Company to Help Students Assess How Their Interests Can Translate to Increased College Readiness and Career Success

Boost by Kaplan, an innovative online program designed to provide pre-college age students with an invaluable career exploration experience to accelerate college and career readiness, has partnered with world-renowned assessment organization The Myers-Briggs Company to provide students with personal insights to help them decide on their e... Read More...
IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel

IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel

Focus Medical has entered into a supply agreement with Israeli-based Ever Green for a potential term of up to ten years Focus Medical will purchase all medical cannabis produced by Ever Green from its 86,000 square foot facility in Moshav Sgula, Israel Supply is secured for the six previously announced binding sales agreements between ... Read More...
Boost by Kaplan Collaborates with Google to Give High School Graduates Insights into Working in Business and Technology

Boost by Kaplan Collaborates with Google to Give High School Graduates Insights into Working in Business and Technology

Boost by Kaplan, an innovative online booster program designed to provide pre-college age students with an invaluable career exploration experience to accelerate college and career readiness, has collaborated with Google to provide insights about what it’s like in the real world of work, the importance of high demand jobs and skill sets, ... Read More...
IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners

IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners

IMC continues execution of German strategy with seven distribution agreements signed, adding axicorp, canymed and Materia Now a total of 1,525kg of sales secured under binding purchase commitments in Germany in the next twelve months All products to be sold under the IMC brand* Currency is in CAD$ unless specified otherwiseTORONTO, GLIL Y... Read More...
IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH

IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH

IMC delivering on German strategy with fourth binding purchase commitment with distribution partner in Germany Zur Rose Pharma GmbH is part of the Zur Rose Group – Europe's largest e-commerce pharmacy * Currency is in CAD$ unless specified otherwise TORONTO, GLIL YAM, Israel and BAD OLDESLOE, Germany, July 15, 2020 - IM Cannabis Corp. ... Read More...
IMC Reports Exercise of Warrants and Options

IMC Reports Exercise of Warrants and Options

Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives * Currency is in CAD$ unless specified otherwise TORONTO and GLIL YAM, Israel, June 30, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, annou... Read More...
IMC Announces Focus Medical's First Import from Canada to Israel, Strengthening International Network

IMC Announces Focus Medical’s First Import from Canada to Israel, Strengthening International Network

Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a global medical cannabis brand Focus Medical has successfully imported approximately 200kg of medical cannabis from Canada, now seven suppliers cultivating under IMC brand across Israel, Spain and Canada IMC brand well positioned for Isra... Read More...
The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

Kaplan Inc., a premier provider of educational programs and services, has teamed up with Hexco, Inc., DBA Hexco Academic, to co-host a national online spelling bee during the week of July 26, 2020. The bee will provide an opportunity for the nation’s top spellers to compete online, giving priority to eighth-grade students who were schedul... Read More...
IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

New generation of evidence-based cannabis products to be launched in IsraelIMC to be exclusive distributor of CannEpil® in Israel for five-year termCannEpil® was developed by MGC Pharma for the treatment of refractory epilepsy* Currency is in CAD$ unless specified otherwiseTORONTO and GLIL YAM, Israel , June 15, 2020 - IM Cannabis Corp. (... Read More...
IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

TORONTO and GLIL YAM, Israel, May 27, 2020  /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) announces that filing of the Company's interim financial statements for the three month period ended March 31, 2020 (the "Q1 Financial Statements") and associated management's discussion and analysis (the "Q1 MD&A", and collective... Read More...
IMC Announces Focus Medical's Successful Import of Medical Cannabis from Spain to Israel

IMC Announces Focus Medical’s Successful Import of Medical Cannabis from Spain to Israel

Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The medical cannabis was supplied by Linneo Health, the Company's strategic supply partner in Spain and an EU-GMP global supplier of medicinal cannabis Six suppliers now cultivating medical cannabis to Focus Medical for sale under the... Read More...
IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

Executing on long-term strategy to build distribution platform across the large German market Sales commitment for 465kg of IMC-branded medical cannabis over the next twelve months Together with other announced binding purchase agreements in Germany, a total of 825kg of IMC-branded medical cannabis is committed for sale over the next tw... Read More...
IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg of medical cannabis between 2020 and 2023 Focus Medical has now secured all the supply required under the six binding pharmacy sales agreements it has signed In 2020, Focus Medical signed binding sales agreements for pharmacies to purchase 33,075kg in medi... Read More...
IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

* Currency is in CAD$ unless specified otherwise PharmYarok entered into a three-year binding sales agreement with Focus Medical for 12,600kg of medical cannabis under the IMC brand PharmYarok to distribute IMC-branded product through its retail pharmacy and its leading e-commerce platform Binding sales agreements signed by Focus Medi... Read More...
IMC Announces Two Additional Binding Sales Agreements by Focus Medical - Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period

IMC Announces Two Additional Binding Sales Agreements by Focus Medical – Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period

Focus Medical has entered into two additional binding sales agreements: Max Pharm for up to 1,500kg over three years and Panaxia for 1,000kg of medical cannabis under the IMC brandMax Pharm adds IMC-branded products to its retail pharmacy and home delivery platform, and Panaxia will launch IMC products across the largest home delivery pla... Read More...
IMC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel's Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

IMC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel’s Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel's largest pharmacy chain, for 13,575kg of IMC branded medical cannabis productsSales to begin in April 2020 through Super-Pharm's omnichannel distribution network including 41 pharmacies licensed to sell medical cannabis, as well as home delivery ... Read More...
IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg

IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg

Focus Medical, entered into a two-year binding agreement to sell 1,000kg of medical cannabis a year to Shor Tabachnik pharmacies The two-year contract is valued at approximately CAD$12 million ; now 4,400kg for an approximate value of CAD$27 million contracted over next three years All medical cannabis sold according to this agreement wil... Read More...
IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand

IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand

IMC continues to build asset-light business model to satisfy rising demand for medical cannabis in Israel with supply of approximately 2,600kg of medical cannabis per year using Focus Medical's proprietary genetics All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 31, ... Read More...
IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna

IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna

Intelicanna , an Israeli cannabis company traded on the Tel Aviv Stock Exchange under the ticker symbol "INTL", to supply a minimum of 500kg and up to 1,000kg of medical cannabis to Focus Medical using Focus Medical's proprietary geneticsAll medical cannabis sold according to this agreement will be under the IMC brandTORONTO and GLIL YAM... Read More...
Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom

Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom

TORONTO and GLIL YAM, Israel, Jan. 30, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is preparing for the expansion of medical cannabis export from Israel in light of the recent news about government approval and the comp... Read More...
IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IMC to become 25% Joint Venture partner for cultivation and processing operation in Greece Preferred supply agreement to diversify sources of EU-GMP medical cannabis for export to Germany and other emerging markets TORONTO and GLIL YAM, Israel, Jan. 28, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world'... Read More...
IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research

IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research

TORONTO and GLIL YAM, Israel , Jan. 7, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (IMCC.CN), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe , is pleased to announce that it has invested in a unique biosynthesis technology by entering into a share purchase ... Read More...
IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019

IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019

IMC currently operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. Focus Medical Herbs Ltd. ("Focus"), a licensed medical cannabis producer in Israel with whom the Company has exclusive commercial agreements, is the first major Israeli licensed producer to utilize the... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
IMCC.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed2.53CAD-1.56%
IMCNF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market2.00USD-2.34%

Delayed data (1h)
NameAgePositionAppointed
James T. Gillis
Chairman of the Board, President, Chief Executive Officer
--Chairman of the Board, President, Chief Executive Officer2010
Steven Michael Mintz
Chief Financial Officer
--Chief Financial Officer2018
Navjit Dhaliwal
Director
--Director2018
Timothy D. Towers
Director
--Director2017
Russell George Williams
Independent Director
--Independent Director2010


Share this page